跳至主要内容
临床试验/SLCTR/2016/013
SLCTR/2016/013尚未招募4 期

Randomized clinical trial on efficacy of telmisartan compared to vitamin E on histopathological improvement in patients with nonalcoholic steatohepatitis.

Bangabandhu Sheikh Mujib Medical University0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Ultrasonographic evidence of fatty liver
  • 2.NAFLD activity score (NAS) greater than or equal to 5 on liver biopsy.

排除标准

  • 1. Significant alcohol intake (more than 20 gm/day).
  • 2. History of taking drugs that may cause fatty liver (i.e. tamoxifen, valproic acid, amiodarone, methotrexate)
  • 3. History of taking drugs that have shown benefit in previous NASH pilot studies (i.e. metformin, thiazolidinediones, fibrates).
  • 4. Chronic liver disease due to any cause (HBV, HCV, Wilson’s disease, drug induced liver injury etc.).
  • 5. Pregnancy.
  • 6. Co-morbid conditions such as (COPD, CKD, CCF etc.)
  • 7. History of recent MI (within 3 months).
  • 8. Liver failure
  • 9. Hypothyroidism.
  • 10. Patient who fails to give consent for paired liver biopsy.

研究者

相似试验

Randomized clinical trial on efficacy of telmisartan... | 临床试验